HANNAH BROWN: Open Payments
NPI 1326608894 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 71 payments from 20 companies in 2025. Trend: 2023 $822 · 2024 $961 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $190 |
| Amgen Inc. | 15 | $140 |
| Novo Nordisk Inc | 7 | $121 |
| PFIZER INC. | 6 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $94 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Dexcom, Inc. | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $42 |
Products named: QULIPTA, NURTEC ODT, XIFAXAN, EVENITY, Ozempic, GEMTESA, Dexcom G6 Transmitter, SPRAVATO.
Industry payments across FL — which companies pay providers there.
